Dopamine biosensing < Dopamine receptor < Dopamine receptors

Facettes :

List of bibliographic references indexed by Dopamine receptor

Number of relevant bibliographic references: 50.
[20-40] [0 - 20][0 - 50][40-49][40-60]

Ident.	Authors (with country if any)	Title
003536 (2002)	C. Lebrun-Frenay [France] ; M. Borg [France]	Choosing the right dopamine agonist for patients with Parkinson's disease
003551 (2002)	K. Ray Chaudhuri [Royaume-Uni] ; Suvankar Pal [Royaume-Uni] ; Christine Brefel-Courbon [France]	'Sleep attacks' or 'Unintended sleep episodes' occur with dopamine agonists: Is this a class effect?
003737 (2001)	S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France]	Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease
003739 (2001)	Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]	Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
003838 (2001)	Olivier Rascol [France] ; Nelly Fabre [France]	Dyskinesia: L-dopa-induced and tardive dyskinesia
003841 (2001)	Thomas Boraud [France] ; Erwan Bezard [France] ; Bernard Bioulac [France] ; Christian E. Gross [France]	Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey
003895 (2000)	Jj Ferreira [France, Portugal] ; M. Galitzky [France] ; Jl Montastruc [France] ; O. Rascol [France]	Sleep attacks and Parkinson's disease treatment
003A60 (2000)	C. Warren Olanow [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France]	Continuous dopamine-receptor stimulation in early Parkinson's disease
003B00 (2000)	P. Derkinderen [France]	Stratégies thérapeutiques conseillées à la phase initiale de la maladie
003B89 (2000)	H. Allain [France] ; A. Destee [France] ; H. Petit [France] ; M. Patay [France] ; S. Schück [France] ; D. Bentue-Ferrer [France] ; P. Le Cavorzin [France]	Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease
003C02 (2000)	C. Imbert [France] ; E. Bezard [France] ; S. Guitraud [France] ; T. Boraud [France] ; C. E. Gross [France]	Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey
003C89 (1999)	O.-K. Hassani [France] ; J. Féger [France]	Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study
003D59 (1999)	Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]	Treatment of Parkinson's disease should begin with a dopamine agonist
003E49 (1999)	Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France]	A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease
003E57 (1999)	C. Brefel-Courbon ; O. Rascol	Scintigraphies cérébrales et syndromes parkinsoniens
003E58 (1999)	J.-L. Baulieu [France] ; C. Prunier [France] ; F. Tranquart [France] ; D. Guilloteau [France] ; VAN DER BORGHT ; DEFEBVRE ; ZANCA ; VIDAILHET ; GRASSET ; PAILLARD ; SAMSON ; BAULAC ; STEINLING ; CLANET ; TOUCHON	Résultats cliniques de la temp de la neurotransmission en pathologie extra-pyramidale. Discussion. Table ronde
003E72 (1999)	G. L. Defer [France]	Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?
003E73 (1999)	O. Rascol [France]	Arguments en faveur du traitement précoce de la maladie de Parkinson par les agonistes dopaminergiques
003E76 (1999)	M. Ziegler [France] ; P. Rondot [France]	Activité du piribédil dans la maladie de Parkinson : Etude multicentrique
004057 (1998)	Philippe Hantraye [France]	Modeling dopamine system dysfunction in experimental animals
004187 (1997-02)		CONTROLE DOPAMINERGIQUE DU NOYAU SYBTHALAMIQUE CHEZ LE RAT NORMAL ET CHEZ LE RAT MODELE DE LA MALADIE DE PARKINSON (RATS 6-OHDA)

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine receptor" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine receptor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine receptor
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024